Related Experiment Video
Updated: Mar 29, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
TNF-α and MTHFR Polymorphisms Associated with Cerebral Palsy in Chinese Infants
Ruiying Hou1, Xiuyu Ren2, Juan Wang2
1Department of Pediatrics, Affiliated Hospital of Weifang Medical College, Weifang, Shandong, China.
Insights
Genetic variations in TNF-α and MTHFR genes are linked to cerebral palsy (CP) development in Chinese infants. Specific gene polymorphisms and their interactions may increase CP risk, suggesting a role in pathogenesis.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Cerebral palsy (CP) pathogenesis is complex, with genetic and environmental factors implicated.
- Tumor Necrosis Factor-alpha (TNF-α) and Methylenetetrahydrofolate Reductase (MTHFR) genes are crucial in inflammatory and metabolic pathways potentially relevant to CP.
Purpose of the Study:
- To investigate the association between specific polymorphisms in TNF-α (rs361525, rs1799724) and MTHFR (rs1476413, rs9651118) genes and the risk of cerebral palsy in Chinese infants.
- To explore the potential interaction effects of these polymorphisms on CP development.
Main Methods:
- Genotyping of 105 CP patients and 114 healthy controls for selected TNF-α and MTHFR polymorphisms using TaqMan allelic discrimination assay.
- Statistical analysis including Odds Ratios (OR) and 95% Confidence Intervals (CI) to assess the strength of associations.
- Subgroup analysis based on gestational age and measurement of TNF-α protein concentrations.
Main Results:
- Significant differences in allele distributions for TNF-α rs1799724 and both allele and genotype distributions for MTHFR rs9651118 between CP cases and controls.
- Significant associations found between TNF-α rs361525 and MTHFR rs9651118 polymorphisms and CP, particularly in subgroups based on gestational age.
- Elevated TNF-α protein levels in patients with the rs361525 GG genotype and a significantly increased risk of CP associated with the interaction of TNF-α rs1799724 and MTHFR rs9651118.
Conclusions:
- Polymorphisms in TNF-α and MTHFR genes are potentially involved in the pathogenesis of cerebral palsy in Chinese infants.
- The interaction between specific TNF-α and MTHFR polymorphisms may contribute to an increased risk of CP.
- These findings highlight the role of genetic factors in CP etiology and suggest potential targets for future research.
Abstract:
This study aims to examine whether the presence of polymorphisms in TNF-α (rs361525 and rs1799724) and MTHFR (rs1476413 and rs9651118) genes is associated with the pathogenesis of cerebral palsy (CP). A total of 105 CP patients and 114 age-, gender-, and ethnicity-matched healthy controls were genotyped for the selected polymorphisms, using TaqMan allelic discrimination assay. Odds ratios (OR) and 95 % confidence intervals (CI) were determined to measure the strength of associations of TNF-α and MTHFR polymorphisms with CP. The proportion of subjects with the gestational age more than 37 weeks or asphyxia was much larger in cases compared with controls (gestational age 63.8 vs. 34.2 %; asphyxia 25.7 vs. 7.9 %). The genotype frequencies of TNF-α rs1799724 were similar between groups (P > 0.05), yet the allele distributions were significantly different (P < 0.05). Both the allele and genotype distributions of MTHFR rs9651118 polymorphism varied significantly between the groups (P < 0.05). Subgroup analysis based on gestational age indicated a significant association between rs361525 and rs9651118 and CP with or without premature. TNF-α protein concentrations were significantly increased among patients with rs361525 GG genotype compared with controls. Also, a significant increase in the risk of CP was observed to be associated with the interactions of TNF-α rs1799724 and MTHFR rs9651118 (OR 2.75, 95 % CI 1.23-6.13). These data suggest that polymorphisms in TNF-α and MTHFR genes might be involved in the pathogenesis of CP in Chinese infants.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase